A detailed history of Wellington Management Group LLP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 11,401,394 shares of RVMD stock, worth $501 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
11,401,394
Previous 13,660,196 16.54%
Holding current value
$501 Million
Previous $530 Million 2.56%
% of portfolio
0.09%
Previous 0.1%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$36.92 - $47.94 $83.4 Million - $108 Million
-2,258,802 Reduced 16.54%
11,401,394 $517 Million
Q2 2024

Aug 13, 2024

SELL
$30.14 - $40.68 $31.8 Million - $42.9 Million
-1,054,530 Reduced 7.17%
13,660,196 $530 Million
Q1 2024

May 15, 2024

BUY
$26.56 - $33.55 $391 Million - $494 Million
14,714,726 New
14,714,726 $474 Million
Q4 2023

Feb 12, 2024

BUY
$18.35 - $34.12 $273 Million - $508 Million
14,882,086 New
14,882,086 $427 Million
Q3 2023

Nov 14, 2023

BUY
$25.17 - $35.05 $7.12 Million - $9.91 Million
282,786 Added 2.75%
10,572,475 $293 Million
Q2 2023

Aug 14, 2023

SELL
$20.28 - $27.0 $2.75 Million - $3.66 Million
-135,679 Reduced 1.3%
10,289,689 $275 Million
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $32.2 Million - $46.7 Million
1,551,394 Added 17.48%
10,425,368 $226 Million
Q4 2022

Feb 13, 2023

BUY
$17.68 - $25.53 $26.4 Million - $38.1 Million
1,492,795 Added 20.22%
8,873,974 $211 Million
Q3 2022

Nov 14, 2022

BUY
$17.46 - $26.0 $21.2 Million - $31.5 Million
1,212,177 Added 19.65%
7,381,179 $146 Million
Q2 2022

Aug 15, 2022

BUY
$14.54 - $27.17 $30.3 Million - $56.6 Million
2,085,013 Added 51.05%
6,169,002 $120 Million
Q1 2022

May 16, 2022

SELL
$17.31 - $26.4 $7.39 Million - $11.3 Million
-426,906 Reduced 9.46%
4,083,989 $104 Million
Q4 2021

Feb 11, 2022

SELL
$24.35 - $33.7 $638,140 - $883,175
-26,207 Reduced 0.58%
4,510,895 $114 Million
Q3 2021

Nov 15, 2021

SELL
$23.95 - $33.41 $25 Million - $34.8 Million
-1,041,946 Reduced 18.68%
4,537,102 $125 Million
Q2 2021

Aug 16, 2021

BUY
$29.0 - $47.44 $48.1 Million - $78.7 Million
1,658,400 Added 42.3%
5,579,048 $177 Million
Q1 2021

May 17, 2021

BUY
$37.21 - $54.43 $137 Million - $201 Million
3,688,457 Added 1588.54%
3,920,648 $180 Million
Q4 2020

Feb 12, 2021

BUY
$30.19 - $45.49 $855,946 - $1.29 Million
28,352 Added 13.91%
232,191 $9.19 Million
Q3 2020

Nov 16, 2020

SELL
$22.61 - $34.8 $1.78 Million - $2.75 Million
-78,902 Reduced 27.91%
203,839 $7.09 Million
Q2 2020

Aug 14, 2020

SELL
$19.65 - $39.34 $1.06 Million - $2.12 Million
-53,924 Reduced 16.02%
282,741 $8.93 Million
Q1 2020

May 14, 2020

BUY
$20.0 - $34.08 $6.73 Million - $11.5 Million
336,665 New
336,665 $7.38 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.85B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.